| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/18/2008 | US20080312338 Formulation |
| 12/18/2008 | US20080312302 Desferasirox Dispersible Tablets |
| 12/18/2008 | US20080312233 Therapeutic Morpholino-Substituted Compounds |
| 12/18/2008 | US20080312210 Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
| 12/18/2008 | US20080312204 Soluble forms of amoxicillin and treatment of animals |
| 12/18/2008 | US20080312139 In an injectable form and to be administered through infiltrations inside and around cutaneous chronic ischemic ulcerative wounds as to prevent diabetic limb amputation |
| 12/18/2008 | US20080312136 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 12/18/2008 | US20080311396 Pressure-Sensitive Adhesive Sheet for Application to Skin |
| 12/18/2008 | US20080311214 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides |
| 12/18/2008 | US20080311213 Topical Formulations Containing Sporopollenin |
| 12/18/2008 | US20080311212 Crystalline isoxazole derivative and pharmaceutical preparation thereof |
| 12/18/2008 | US20080311211 Easily Dispersible Lipidic Phase |
| 12/18/2008 | US20080311210 Pharmaceutical composition for use as a laxative |
| 12/18/2008 | US20080311209 Topical compositions comprising nanoparticles of an isoflavone |
| 12/18/2008 | US20080311208 Pharmaceutical Formulations Useful in the Treatment of Insomnia |
| 12/18/2008 | US20080311207 Micelles and Nanoemulsions for Preventive and Reactive Treatment of Atherosclerosis |
| 12/18/2008 | US20080311206 Anti-Chafing Compositions Comprising Boron Nitride |
| 12/18/2008 | US20080311205 Abuse resistant drug formulation |
| 12/18/2008 | US20080311204 Stable oral formulation containing benzimidazole derivative |
| 12/18/2008 | US20080311203 Oral Formulation of Anhydrous Olanzapine Form I |
| 12/18/2008 | US20080311202 Pharmaceutical Composition Containing Donepezil Hydrochloride, Tablets Produced Therefrom and Methods for Producing the Same |
| 12/18/2008 | US20080311201 Modified release solid or semi-solid dosage forms |
| 12/18/2008 | US20080311200 Controlled Slow Release Formulation of Thiamine and Use Thereof in the Treatment of Pathologies Connected to Defective Process of Learning and Memorization |
| 12/18/2008 | US20080311199 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311198 Tamper-resistant oral opioid agonist formulations |
| 12/18/2008 | US20080311197 Process for the production of an abuse-proofed dosage form |
| 12/18/2008 | US20080311196 All Day Rhinitic Condition Treatment Regimen |
| 12/18/2008 | US20080311195 Basis particles, method for manufacturing the same, and orally-disintegrating tablet |
| 12/18/2008 | US20080311194 Dispersible Tablets Comprising Deferasirox |
| 12/18/2008 | US20080311193 Sustained Release Formulation of Alprazolam |
| 12/18/2008 | US20080311192 Enteric-Coated Glucosinolates And Beta-Thioglucosidases |
| 12/18/2008 | US20080311191 Multi-Layer Tablets and Bioadhesive Dosage Forms |
| 12/18/2008 | US20080311190 Thrombin-Free Biological Adhesive and Use Thereof as a Medicament |
| 12/18/2008 | US20080311189 Compositions Comprising Organometallic Molybdenum Compounds For Treating Cancer |
| 12/18/2008 | US20080311188 Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 12/18/2008 | US20080311187 Crush resistan delayed-release dosage form |
| 12/18/2008 | US20080311186 Composition Having Effect on Treatment and Prevention of Dry Eye Syndrome |
| 12/18/2008 | US20080311185 Deregulated Genes and/or Processes in Inflammatory Arthritis |
| 12/18/2008 | US20080311184 Method for developing, testing, and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
| 12/18/2008 | US20080311183 Novel Inhibitors of Pyruvate Kinase as Therapeutic Agents for Cancer |
| 12/18/2008 | US20080311182 Multistage delivery of active agents |
| 12/18/2008 | US20080311181 Serum-Stable Amphoteric Liposomes |
| 12/18/2008 | US20080311180 Method of Preventive On-Demand Hormonal Contraception |
| 12/18/2008 | US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders |
| 12/18/2008 | US20080311178 Gel composition and use thereof |
| 12/18/2008 | US20080311177 Self Assembled Films for Protein and Drug Delivery Applications |
| 12/18/2008 | US20080311176 Drug Condensation Aerosols And Kits |
| 12/18/2008 | US20080311173 Implantable or insertable medical devices for controlled delivery of a therapeutic agent |
| 12/18/2008 | US20080311172 Programmed-release, nanostructured biological construct |
| 12/18/2008 | US20080311171 Implantable polymeric device for sustained release of dopamine agonist |
| 12/18/2008 | US20080311170 Implant device release agents and methods of using same |
| 12/18/2008 | US20080311169 Composition Comprising Ginsenosides for Treating or Preventing Angiostenosis and Restenosis |
| 12/18/2008 | US20080311165 Copper Containing Materials for Treating Wounds, Burns and Other Skin Conditions |
| 12/18/2008 | US20080311162 Film to encapsulate pharmaceutical, agrochemical, detergent active ingredients; fill material less compacted than in a tablet but more than in a capsule; controlled release; fewer, lower quantities of excipients |
| 12/18/2008 | US20080311161 Compositions and Methods for Enhanced Gastrointestinal Stability of Oligopeptides and Polypeptides |
| 12/18/2008 | US20080311160 Clear Pharmaceutical Aqueous Emulsion Composition Which Comprises Propofol and Process for Preparing this Composition |
| 12/18/2008 | US20080311105 Reversibly Inactivated Acidified Plasmin |
| 12/18/2008 | US20080311080 Bifidobacterium in the treatment of inflammatory disease |
| 12/18/2008 | US20080311053 Fluorinated phosphate ester surfactant and fluorinated alcohol compositions |
| 12/18/2008 | US20080311052 Isis Pharmaceuticals, Inc. |
| 12/18/2008 | US20080311051 Caspase-2 Inhibitors And Their Biological Applications |
| 12/18/2008 | US20080311050 Method for Producing Shape Memory Effects in Hair in Connection with Hydrophobic Active Ingredients |
| 12/18/2008 | US20080311049 Thermoforming by extrusion without discoloration; controlled release |
| 12/18/2008 | US20080311045 Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo |
| 12/18/2008 | DE102007028025A1 Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an molekularem Sauerstoff, grenzflächenaktiven Glucosederivaten und vorteilhafterweise einer oder mehreren UV-Licht absorbierenden Substanzen Cosmetic or dermatological preparations containing molecular oxygen, surface-active glucose derivatives and advantageously one or more UV-absorbing substances |
| 12/18/2008 | DE102007027781A1 Cosmetic and/or pharmaceutical preparations, useful as e.g. creams, lotions, sprayable emulsions, transparent and semi-transparent gels, comprises a quaternary polymer |
| 12/18/2008 | DE102007027067A1 Verfahren zur Herstellung eines Arzneimittels enthaltend Vardenafil Hydrochlorid Trihydrat A process for preparing a pharmaceutical composition comprising vardenafil hydrochloride trihydrate |
| 12/18/2008 | CA2727531A1 Uniformly abrasive confectionery product and process therefor |
| 12/18/2008 | CA2692164A1 Hyperbranched polymers based on cyclodextrins and poly(amidoamines) for the controlled release of insoluble drugs |
| 12/18/2008 | CA2690874A1 Improvements in and relating to mammalian reproduction |
| 12/18/2008 | CA2690771A1 Injectable polymer-lipid blend for localized drug delivery |
| 12/18/2008 | CA2690715A1 Peptide slow-release formulations |
| 12/18/2008 | CA2690600A1 A drug delivery system for the prevention of cerebral vasospasm |
| 12/18/2008 | CA2690036A1 Pack |
| 12/18/2008 | CA2689978A1 Extended release formulation and method of treating adrenergic dysregulation |
| 12/18/2008 | CA2687717A1 Formulations and methods for treating dry eye |
| 12/18/2008 | CA2687505A1 Pharmaceutical compositions and methods for enhancing targeting of therapeutic compounds to the central nervous system |
| 12/18/2008 | CA2687500A1 Process for the preparation of a medicament comprising vardenafil hydrochloride trihydrate |
| 12/18/2008 | CA2686548A1 Concentrate esmolol |
| 12/18/2008 | CA2684699A1 Intradermal influenza vaccine |
| 12/18/2008 | CA2683313A1 Benefit agent containing delivery particle |
| 12/17/2008 | EP2002864A1 Cosmetic and/or dermatological capsule |
| 12/17/2008 | EP2002832A2 Composition containing lignan compound |
| 12/17/2008 | EP2002828A2 Solid pharmaceutical preparation |
| 12/17/2008 | EP2002826A1 Titratable dosage transdermal delivery system |
| 12/17/2008 | EP2002825A1 Pharmaceutical compositions comprising orlistat |
| 12/17/2008 | EP2002824A2 Gel composition and use thereof |
| 12/17/2008 | EP2001981A1 Process for the preparation of water-in-oil and oil-in-water nanoemulsions |
| 12/17/2008 | EP2001521A2 Stabilized, sterilized collagen scaffolds with active adjuncts attached |
| 12/17/2008 | EP2001500A2 Formulations for ecallantide |
| 12/17/2008 | EP2001498A2 Pharmaceutical compositions |
| 12/17/2008 | EP2001497A2 Pharmaceutical compositions |
| 12/17/2008 | EP2001477A2 Paclitaxel combination |
| 12/17/2008 | EP2001465A1 Antibiotic compositions of modified release and process of production thereof |
| 12/17/2008 | EP2001460A2 Compositions for promoting hair growth |
| 12/17/2008 | EP2001453A2 Apparatus and method for transdermal delivery of parathyroid hormone agents to prevent or treat osteopenia |
| 12/17/2008 | EP2001452A2 Calcium phosphate complex in acid containing chewing gum |
| 12/17/2008 | EP2001451A1 Non-homogenous dosage form coatings |
| 12/17/2008 | EP2001450A2 Directly compressible composite for orally disintegrating tablets |
| 12/17/2008 | EP2001449A2 Modified release clopidogrel formulation |